Upgrade to SI Premium - Free Trial

Jazz Pharmaceuticals (JAZZ) PT Raised to $232 at Piper Sandler

March 19, 2026 8:32 AM
Piper Sandler analyst David Amsellem raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $232.00 (from $219.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change